Log in

CVE:TCITarget Capital Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$0.01
52-Week Range N/A
Volume12,000 shs
Average Volume165,650 shs
Market CapitalizationC$1.60 million
P/E RatioN/A
Dividend YieldN/A
Target Capital Inc. is a private equity and venture capital firm specializing in acquisitions, startups, early stage and buyout companies. It owns interests in future commissions on claims processed through the Olympia Trust Health Plan. It invests in listed public companies, trailer fee rights, notes receivable, reporting issuers, and controlled private companies. The firm also invests in land development corporations. It seeks to invest in medical and recreational cannabis industry, and in businesses offering from cultivators to ancillary supportive products and services. It prefers to invest in Canada, Europe and United States. It prefers to invest in companies that generate 10x ROI Within 3 Years. It prefers to take majority stake. It prefers to exit through acquisition. Target Capital Inc. was incorporated in 1993 and is headquartered in Calgary, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Asset Management



Sales & Book Value

Annual SalesC$774,566.00
Book ValueC$0.03 per share



Market CapC$1.60 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive TCI News and Ratings via Email

Sign-up to receive the latest news and ratings for TCI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Target Capital (CVE:TCI) Frequently Asked Questions

Has Target Capital been receiving favorable news coverage?

News articles about TCI stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Target Capital earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Target Capital

Who are some of Target Capital's key competitors?

What other stocks do shareholders of Target Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Target Capital investors own include Cloudera (CLDR), Glacier Bancorp (GBCI), Giga-tronics (GIGA), InterDigital Wireless (IDCC), PepsiCo (PEP), Parkland Fuel (PKI), Sienna Senior Living (SIA), Terex (TEX), Asanko Gold (AKG) and Aguia Resources (AGRL).

Who are Target Capital's key executives?

Target Capital's management team includes the following people:
  • Mr. Shahin Mottahed, Chairman, Pres & CEO
  • Mr. David Cheadle, Chief Financial Officer
  • Mr. Jason Kujath, Gen. Counsel (Age 34)
  • Mr. Bill McDonald, Exec. VP of Corp. Devel. and Director
  • Mr. Sanjib Singh Gill, Corp. Sec. (Age 43)

What is Target Capital's stock symbol?

Target Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "TCI."

How do I buy shares of Target Capital?

Shares of TCI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Target Capital?

Target Capital has a market capitalization of C$0.00 and generates C$774,566.00 in revenue each year.

What is Target Capital's official website?

The official website for Target Capital is www.targetcapitalinc.com.

How can I contact Target Capital?

The company can be reached via phone at 403-351-1779.

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.